Cancer proteomics--an evolving battlefield. Conference on Cancer Proteomics 2009: Mechanistic Insights, Technological Advances & Molecular Medicine.
作者信息
Collins Ben C, Lau Thomas Y K, O'Connor Darran P, Hondermarck Hubert
机构信息
UCD Conway Institute, UCD School of Biomolecular and Biomedical Science, University College Dublin, Belfield, Dublin, Ireland.
出版信息
EMBO Rep. 2009 Nov;10(11):1202-5. doi: 10.1038/embor.2009.222. Epub 2009 Oct 2.
Abstract
摘要
相似文献
1
Cancer proteomics--an evolving battlefield. Conference on Cancer Proteomics 2009: Mechanistic Insights, Technological Advances & Molecular Medicine.癌症蛋白质组学——一个不断演变的战场。2009年癌症蛋白质组学会议：机理洞察、技术进展与分子医学。
EMBO Rep. 2009 Nov;10(11):1202-5. doi: 10.1038/embor.2009.222. Epub 2009 Oct 2.
2
[Which molecular biology techniques must conform to the armamentarium for basic research in uro-oncology?].[哪些分子生物学技术必须符合泌尿肿瘤学基础研究的设备要求？]
Arch Esp Urol. 2013 Jun;66(5):409-15.
3
From bytes to bedside: data integration and computational biology for translational cancer research.从字节到床边：用于转化癌症研究的数据整合与计算生物学
PLoS Comput Biol. 2007 Feb 23;3(2):e12. doi: 10.1371/journal.pcbi.0030012.
4
Molecular oncology in the post-genomic era: the challenge of proteomics.
Trends Mol Med. 2004 Jan;10(1):24-32. doi: 10.1016/j.molmed.2003.11.001.
5
Proteomics for Early Diagnostics.用于早期诊断的蛋白质组学。
J Craniofac Surg. 2015 Jun;26(4):1013-4. doi: 10.1097/SCS.0000000000001705.
6
New oncology strategy: molecular targeting of cancer cells.新的肿瘤学策略：癌细胞的分子靶向治疗
Medsurg Nurs. 2004 Jun;13(3):191-5.
7
Translational oncology toward benefiting cancer patients: the Sun Yat-sen University Cancer Center experience.转化肿瘤学造福癌症患者：中山大学肿瘤防治中心的经验
Sci China Life Sci. 2016 Oct;59(10):1057-1062. doi: 10.1007/s11427-012-4398-4.
8
Can we deconstruct cancer, one patient at a time?我们能否一次一个患者地对癌症进行解构？
Trends Genet. 2013 Jan;29(1):6-10. doi: 10.1016/j.tig.2012.09.004. Epub 2012 Oct 23.
9
Molecular network analysis using reverse phase protein microarrays for patient tailored therapy.使用反相蛋白质微阵列进行分子网络分析以实现患者个性化治疗。
Adv Exp Med Biol. 2008;610:177-86. doi: 10.1007/978-0-387-73898-7_13.
10
[Functional proteomics in oncology: to understand more than to describe].[肿瘤学中的功能蛋白质组学：理解而非描述]
Med Sci (Paris). 2007 Mar;23 Spec No 1:27-30. doi: 10.1051/medsci/2007231s27.
本文引用的文献
1
Tissue microarrays as a tool in the discovery and validation of tumor markers.组织微阵列作为肿瘤标志物发现与验证的工具。
Methods Mol Biol. 2009;520:151-61. doi: 10.1007/978-1-60327-811-9_11.
2
Transfer and multiplex immunoblotting of a paraffin embedded tissue.石蜡包埋组织的转印和多重免疫印迹
Methods Mol Biol. 2009;536:139-48. doi: 10.1007/978-1-59745-542-8_16.
3
The Human Protein Atlas--a tool for pathology.人类蛋白质图谱——病理学工具。
J Pathol. 2008 Dec;216(4):387-93. doi: 10.1002/path.2440.
4
Comprehensive mass-spectrometry-based proteome quantification of haploid versus diploid yeast.基于质谱法对单倍体与二倍体酵母进行蛋白质组全面定量分析。
Nature. 2008 Oct 30;455(7217):1251-4. doi: 10.1038/nature07341. Epub 2008 Sep 28.
5
Precision proteomics: the case for high resolution and high mass accuracy.精准蛋白质组学：高分辨率和高质量精度的实例
Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18132-8. doi: 10.1073/pnas.0800788105. Epub 2008 Sep 25.
6
Molecular imaging of proteins in tissues by mass spectrometry.通过质谱对组织中的蛋白质进行分子成像。
Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18126-31. doi: 10.1073/pnas.0801374105. Epub 2008 Sep 5.
7
A genecentric Human Protein Atlas for expression profiles based on antibodies.基于抗体的、以基因为中心的人类蛋白质图谱用于表达谱分析。
Mol Cell Proteomics. 2008 Oct;7(10):2019-27. doi: 10.1074/mcp.R800013-MCP200.
8
Accurate inclusion mass screening: a bridge from unbiased discovery to targeted assay development for biomarker verification.精确的纳入质量筛选：从无偏发现到用于生物标志物验证的靶向分析方法开发的桥梁。
Mol Cell Proteomics. 2008 Oct;7(10):1952-62. doi: 10.1074/mcp.M800218-MCP200. Epub 2008 Jun 4.
9
Mining the plasma proteome for cancer biomarkers.挖掘血浆蛋白质组以寻找癌症生物标志物。
Nature. 2008 Apr 3;452(7187):571-9. doi: 10.1038/nature06916.
10
Raman nanoparticle probes for antibody-based protein detection in tissues.用于组织中基于抗体的蛋白质检测的拉曼纳米颗粒探针。
J Histochem Cytochem. 2008 Apr;56(4):371-9. doi: 10.1369/jhc.7A7313.2007. Epub 2007 Dec 10.
Zotero 插件